Artwork

Konten disediakan oleh CRC Group. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh CRC Group atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

The Skinny on GLP-1s for Healthcare Industry Risks

24:44
 
Bagikan
 

Manage episode 445801726 series 2822097
Konten disediakan oleh CRC Group. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh CRC Group atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Ever wondered how the latest advancements in GLP-1 medications are revolutionizing the treatment of diabetes and obesity? Join us for an insightful conversation with healthcare brokers Scott Scheiblin and Chip Wenges as they unravel the complexities and opportunities these groundbreaking drugs bring to healthcare providers. You'll discover the hidden pitfalls of improper prescribing practices, the looming threat of regulatory scrutiny over compounded medications, and the challenges posed by insurers limiting coverage to branded versions. As the demand for GLP-1s skyrockets, we discuss the implications and potential repercussions that could follow.

Visit REDYIndex.com for critical pricing analysis and a snapshot of the marketplace.

Do you want to take your career to the next level? Join #TeamCRC to get access to best-in-class tools, data, exclusive programs, and more! Send your resume to [email protected] today!

  continue reading

Chapter

1. The Skinny on GLP-1s for Healthcare Industry Risks (00:00:00)

2. Can you briefly explain what GLP-1 medications are and why their use is exploding right now? (00:02:03)

3. Walk us through some of the key risks for healthcare providers that are jumping into the GLP-1 fray. (00:03:32)

4. We’ve seen some FDA advisories around compounded versions of GLP-1s. How do you see this impacting providers? (00:04:38)

5. Are insurers pulling back? (00:06:00)

6. Do you anticipate litigation becoming a bigger concern for healthcare providers? (00:08:38)

7. What steps should healthcare providers be taking right now to mitigate these risks? (00:10:47)

8. Why is Team CRC the right partner? (00:18:41)

9. Rapid Fire! (00:20:36)

96 episode

Artwork
iconBagikan
 
Manage episode 445801726 series 2822097
Konten disediakan oleh CRC Group. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh CRC Group atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Ever wondered how the latest advancements in GLP-1 medications are revolutionizing the treatment of diabetes and obesity? Join us for an insightful conversation with healthcare brokers Scott Scheiblin and Chip Wenges as they unravel the complexities and opportunities these groundbreaking drugs bring to healthcare providers. You'll discover the hidden pitfalls of improper prescribing practices, the looming threat of regulatory scrutiny over compounded medications, and the challenges posed by insurers limiting coverage to branded versions. As the demand for GLP-1s skyrockets, we discuss the implications and potential repercussions that could follow.

Visit REDYIndex.com for critical pricing analysis and a snapshot of the marketplace.

Do you want to take your career to the next level? Join #TeamCRC to get access to best-in-class tools, data, exclusive programs, and more! Send your resume to [email protected] today!

  continue reading

Chapter

1. The Skinny on GLP-1s for Healthcare Industry Risks (00:00:00)

2. Can you briefly explain what GLP-1 medications are and why their use is exploding right now? (00:02:03)

3. Walk us through some of the key risks for healthcare providers that are jumping into the GLP-1 fray. (00:03:32)

4. We’ve seen some FDA advisories around compounded versions of GLP-1s. How do you see this impacting providers? (00:04:38)

5. Are insurers pulling back? (00:06:00)

6. Do you anticipate litigation becoming a bigger concern for healthcare providers? (00:08:38)

7. What steps should healthcare providers be taking right now to mitigate these risks? (00:10:47)

8. Why is Team CRC the right partner? (00:18:41)

9. Rapid Fire! (00:20:36)

96 episode

Semua episode

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat

Dengarkan acara ini sambil menjelajah
Putar